Drug touted by US president has no benefit, warn experts

The experts’ panel said in guidelines for treatment that except for the purposes of clinical trials, it “recommends against” the use of the antimalarial drug Hydroxychloroquine (HCQ) plus Azithromycin, an antibiotic, “because of the potential for toxicities”.

from Hindustan Times - world https://bit.ly/2xTpyd3
https://ift.tt/2zbki14